Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureCydney Nichols, Noelle Frey, Saar Gill, Elizabeth Hexner, Rebecca L. Hirsh, Nasheed M. Hossain, Alison Loren, Mary Ellen Martin, Shannon R. McCurdy, Pashna Munshi, Linda Perry, Jacqueline Smith, Leslie Litzky, Emily Baumrin, Vivek N. Ahya, David L. Porter
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Pulmonary Alveolar Proteinosis
10.1038/s41572-019-0066-3 · 2019
Pulmonary Alveolar Proteinosis After Allogeneic Hematopoietic Stem‐Cell Transplantation in Adults: A French Societe Francophone de Greffe de Moelle et Therapie Cellulaire Survey
10.1016/j.chest.2021.05.056 · 2021
Sirolimus‐Induced Secondary Pulmonary Alveolar Proteinosis
10.1016/j.rmcr.2021.101566 · 2022
Sirolimus‐Induced Pulmonary Alveolar Proteinosis in the Context of Hematopoietic Stem Cells Transplant Rejection: A Case Report
10.1016/j.transproceed.2021.12.006 · 2022
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft‐Versus‐Host Disease: IV. The 2020 Highly Morbid Forms Report
10.1016/j.jtct.2021.06.001 · 2021
Increasing Incidence of Chronic Graft‐Versus‐Host Disease in Allogeneic Transplantation: A Report From the Center for International Blood and Marrow Transplant Research
10.1016/j.bbmt.2014.10.021 · 2015
FDA‐Approved Therapies for Chronic GVHD
10.1182/blood.2024026633 · 2025
Updates in Chronic Graft‐Versus‐Host Disease Management
10.1002/ajh.27040 · 2023
Extracorporeal Photopheresis as an Immunomodulatory Treatment Modality for Chronic GvHD and the Importance of Emerging Biomarkers
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
10.3389/fimmu.2023.1086006 · 2023
Axatilimab in Recurrent or Refractory Chronic Graft‐Versus‐Host Disease
10.1056/nejmoa2401537 · 2024
Pulmonary Alveolar Proteinosis: From Classification to Therapy
10.1183/20734735.0018-2020 · 2020
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft‐Versus‐Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
10.1016/j.bbmt.2014.12.001 · 2015
Pulmonary Alveolar Proteinosis: Progress in the First 44 Years
10.1164/rccm.2109105 · 2002
Transbronchial Lung Biopsy (TBLB) in Diagnosing Pulmonary Alveolar Proteinosis (PAP): Forgotten Role in Australia?
10.1002/rcr2.129 · 2015
Pulmonary Alveolar Proteinosis
10.1055/s-0032-1325160 · 2012
Spontaneous Factor VIII Inhibitor Occurring in Association With Chronic Graft‐Versus‐Host Disease
10.1002/ajh.2830450309 · 1994
Rituximab as a Treatment for Factor VIII Inhibitor in a Patient With Chronic GVHD
10.1038/bmt.2013.229 · 2014
No additional external references are available.